Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
05/30/2006 | CA2195243C Triazole compounds and the use thereof |
05/30/2006 | CA2141692C Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
05/26/2006 | WO2006055760A1 Triazole compounds that modulate hsp90 activity |
05/26/2006 | WO2006055463A2 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
05/26/2006 | WO2006055462A1 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
05/26/2006 | WO2006055184A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
05/26/2006 | WO2006054830A1 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
05/26/2006 | WO2006054700A1 Optical filter |
05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
05/26/2006 | WO2006053643A1 N-heterocyclyl phthalic acid diamides as insecticides |
05/26/2006 | WO2006053555A2 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase |
05/26/2006 | WO2005118551A3 Thrombopoietin activity modulating compounds and methods |
05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
05/26/2006 | CA2588766A1 Heterocycle substituted carboxylic acids |
05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
05/26/2006 | CA2587678A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
05/26/2006 | CA2587482A1 N-heterocyclyl phthalic acid diamides as insecticides |
05/26/2006 | CA2587427A1 Kinase inhibitors |
05/26/2006 | CA2586612A1 Triazole compounds that modulate hsp90 activity |
05/25/2006 | WO2005033098A9 Salts and polymorphs of a pyrrole-substituted indolinone compound |
05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
05/25/2006 | US20060111417 Amorphous telmisartan |
05/25/2006 | US20060111411 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
05/25/2006 | US20060111404 Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide |
05/25/2006 | US20060111403 Cyano anthranilamide insecticides |
05/25/2006 | US20060111402 Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
05/25/2006 | US20060111377 Heterocyclic derivatives |
05/25/2006 | US20060111370 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 5-(3-(3-trifluoromethoxyphenyl)phenyl)-2,5-dimethyl-1,2,4-oxadiazinan-3-imine, for example |
05/25/2006 | US20060111369 Synthesis, characterization and biological action of optically active isomers of floxacins |
05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
05/25/2006 | US20060111367 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide |
05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
05/25/2006 | US20060111360 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
05/25/2006 | US20060111355 6-({(2S)-4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]-2-methylpiperazin-1-yl}methyl)quinoxaline; orally bioavailable; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, primary hirsutism, or LH surge |
05/25/2006 | US20060111338 2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
05/24/2006 | EP1658281A2 A method of removing the triphenylmethane protecting group |
05/24/2006 | EP1658280A1 Quinazoline derivatives as angiogenesis inhibitors |
05/24/2006 | EP1658274A2 Inhibitors of cathepsin s |
05/24/2006 | EP1658269A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
05/24/2006 | DE102004056226A1 Neuartige Inhibitoren der Lysyloxidase Novel inhibitors of lysyl oxidase |
05/24/2006 | DE102004055582A1 N-Heterocyclyl-phthalsäurediamide N-heterocyclyl-Phthalamides |
05/24/2006 | CN1777592A Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
05/24/2006 | CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors |
05/24/2006 | CN1775779A Diphenyl ether azole derivative bioelectronic transmission material, and its new preparing method and use |
05/24/2006 | CN1775777A New triazole organic compounds comprising benzotriazole, and its preparing method and use |
05/24/2006 | CN1775776A Ligustrazine alkyl piperazine derivative, and its preparing method and medicinal composition and use |
05/24/2006 | CN1775775A Method for preparing dimaleimide compounds |
05/24/2006 | CN1775752A Optical pure diamide compound and its use |
05/24/2006 | CN1257158C N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity |
05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
05/23/2006 | US7049314 Cyclopentyl indole derivatives |
05/23/2006 | US7049310 Therapy for bacteria infections |
05/23/2006 | US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
05/23/2006 | US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing |
05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
05/18/2006 | WO2006053116A2 Rizatriptan process |
05/18/2006 | WO2006053109A1 Heteroaryl compounds |
05/18/2006 | WO2006052264A2 Synthesis, characterization and biological action of optically active isomers of floxacins |
05/18/2006 | WO2006052190A1 Indazole sulphonamide derivatives |
05/18/2006 | WO2006051891A1 Production method of pyrimidine compounds |
05/18/2006 | WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
05/18/2006 | WO2006051502A2 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
05/18/2006 | WO2006051312A1 Gastrin and cholecystokinin receptor ligands |
05/18/2006 | WO2006051290A2 Compounds for treating protein-kinase mediated disorders |
05/18/2006 | WO2006050964A2 Indinavir derivatives useful in immunoassay |
05/18/2006 | WO2006050923A1 Polymorph form of irbesartan |
05/18/2006 | WO2006050922A1 Process for the synthesis of tetrazoles |
05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
05/18/2006 | US20060106225 N3 alkylated benzimidazole derivatives as MEK inhibitors |
05/18/2006 | US20060106218 Substituted piperazines |
05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
05/18/2006 | US20060106084 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones |
05/18/2006 | US20060106079 Reacting methyl 2-methyl-3-(pyrazin-2-yl)-3-oxopropionate with phosphorus pentasulfide in presence of mixed solvent of toluene andxylene under reflux to produce an oltipraz crude crystal; recrystallization; sulfiding, cyclization |
05/18/2006 | US20060106069 4-(5-Chloro-2-isopropylaminopyridin-4-yl)-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic agent; study of intracellular signal transduction pathways; evaluation of new kinase inhibitors |
05/18/2006 | US20060106068 Sigma receptor inhibitors |
05/18/2006 | US20060106059 Melanocortin receptor ligands |
05/18/2006 | US20060106058 Chemical compounds |
05/18/2006 | US20060106042 Substituted heterocyclpyrmidines |
05/18/2006 | US20060106032 selective inhibitor of protease activated receptor (PAR)-4-dependent activation; inhibits low thrombin-induced Ca++ signal and thromboxane production; inhibit vascular endothelial growth factor induced cell proliferation, migration, tube formation in human umbilial vein endothelial cells; antitumor agent |
05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
05/18/2006 | US20060106029 antitumor agent; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl) methyl)-N-thiazol-2-ylpyridin-2-amine; excellent potentiation; side effects reduction |
05/18/2006 | US20060106028 Polycyclic aromatics and derivatives thereof and processes for their preparation |
05/18/2006 | US20060106027 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yI)-amine derivatives |
05/18/2006 | US20060106016 Dicarboxamide derivatives |